ETERNA THERAPEUTICS INC (ERNA) Stock Analyst Earnings Estimates
NASDAQ:ERNA - Nasdaq - US1140822099 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 68K | ||
| EBITDA YoY % growth | -27.31M -646.17% | -27.07M 0.88% | -20.591M 23.93% | |
| EBIT YoY % growth | -27.43M -407.96% | -27.23M 0.73% | -20.675M 24.07% | |
| Operating Margin | N/A | N/A | -30,404.41% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -1.03 58.63% | % | ||
| Q3 2022 Q2Q % growth | -2.49 -13.18% | -2.24 | -0.25 | -10.96% |
| Q2 2022 Q2Q % growth | -1.20 | -2.65 | 1.45 | 54.75% |
| Q1 2022 Q2Q % growth | -3.40 | -2.86 | -0.54 | -19.05% |
| Q4 2021 Q2Q % growth | -3.20 | -2.55 | -0.65 | -25.49% |
| Q3 2021 Q2Q % growth | -2.20 | -1.63 | -0.57 | -34.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 487K 874.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | 1.18M -77.18% | % | ||
| Q3 2020 Q2Q % growth | 1.48M -67.69% | % | ||
| Q2 2020 Q2Q % growth | 750K -85.66% | % | ||
| Q1 2020 Q2Q % growth | 2.39M -50.52% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |